Your browser doesn't support javascript.
loading
Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery.
Zhan, Yanai; Kost-Alimova, Maria; Shi, Xi; Leo, Elisabetta; Bardenhagen, Jennifer P; Shepard, Hannah E; Appikonda, Srikanth; Vangamudi, Bhavatarini; Zhao, Shuping; Tieu, Trang N; Jiang, Shiming; Heffernan, Timothy P; Marszalek, Joseph R; Toniatti, Carlo; Draetta, Giulio; Tyler, Jessica; Barton, Michelle; Jones, Philip; Palmer, Wylie S; Geck Do, Mary K; Andersen, Jannik N.
Afiliação
  • Zhan Y; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Kost-Alimova M; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Shi X; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Leo E; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Bardenhagen JP; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Shepard HE; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Appikonda S; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Vangamudi B; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Zhao S; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Tieu TN; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Jiang S; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Heffernan TP; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Marszalek JR; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Toniatti C; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Draetta G; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Tyler J; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Barton M; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Jones P; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Palmer WS; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Geck Do MK; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
  • Andersen JN; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 USA.
Epigenetics Chromatin ; 8: 37, 2015.
Article em En | MEDLINE | ID: mdl-26396593
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Epigenetics Chromatin Ano de publicação: 2015 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Epigenetics Chromatin Ano de publicação: 2015 Tipo de documento: Article País de publicação: Reino Unido